From: Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Characteristic | Number of panelists | Mean ± SD |
---|---|---|
Specialty | Â | Â |
 Pulmonology | 13 |  |
 Rheumatology | 12 |  |
Experience treating SSc-ILD (n = 25) |  | 16.68 ± 9.68 |
  ≤ 10 years | 6 |  |
 11–20 years | 14 |  |
  > 20 years | 5 |  |
Patients with SSc-ILD treated in entire career (n = 24) |  | 369.58 ± 341.74 |
  ≤ 500 | 21 |  |
 501–1000 | 2 |  |
  > 1000 | 1 |  |
Patients with SSc-ILD treated last year (n = 23) |  | 80.04 ± 73.23 |
  ≤ 50 | 11 |  |
 51–150 | 10 |  |
  > 150 | 2 |  |